Carcinoma, Large Cell: Clinical Trials

5 trials for Carcinoma, Large Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Terminated 1, Withdrawn 1
Phase 21Completed 1

Follow Carcinoma, Large Cell: new trials by email Literature Review of Carcinoma, Large Cell trials Research Report on Carcinoma, Large Cell

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Temoporfin - Carcinoma, Non-Small-Cell-Lung
Phase 1WithdrawnUniversity of Arkansas2012-07-012014-01-15
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
PF-02341066/PF-00299804 - Carcinoma, Non-Small Cell Lung, Adenocarcinoma
Phase 1TerminatedNational Cancer Institute (NCI)202011-09-012019-12-17
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Motexafin Gadolinium Injection - Non-Small-Cell Lung Carcinoma, Carcinoma, Bronchogenic
Phase 1CompletedPharmacyclics LLC.362004-11-012009-04-03
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
Drug: Hyperacute Lung Cancer Cell Vaccine - Non-small Cell Carcinoma, Adenocarcinoma of Lung
Phase 1 / Phase 2CompletedNewLink Genetics Corporation542003-11-012020-05-28
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
EP2101 - Carcinoma, Non-Small-Cell Lung, Lung Neoplasm
Phase 1CompletedEpimmune182003-01-012010-03-24

Narrower conditions

Carcinoma, Non-Small-Cell Lung (5)  ·  Lung Neoplasms (5)  ·  Carcinoma, Squamous Cell (4)  ·  Adenocarcinoma (2)  ·  Adenocarcinoma of Lung (2)  ·  Carcinoma, Bronchogenic (1)  ·  Neoplasms (1)

Broader conditions

Bronchial Neoplasms (5)  ·  Carcinoma (5)  ·  Lung Diseases (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Neoplasms (5)  ·  Thoracic Neoplasms (5)  ·  Carcinoma, Bronchogenic (4)  ·  Neoplasms (4)  ·  Neoplasms, Squamous Cell (4)  ·  Adenocarcinoma (2)

Interventions

motexafin gadolinium (1)  ·  temoporfin (1)

Sponsors

Epimmune (1)  ·  National Cancer Institute (NCI) (1)  ·  NewLink Genetics Corporation (1)  ·  Pharmacyclics LLC. (1)  ·  University of Arkansas (1)

Countries

United States (5)

Top investigators

Arun Rajan, M.D. (2)  ·  Mary E Meek, MD (1)